Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: Validity and variability

Parkinsonism and Related Disorders

Volumn 17, Issue 3, 2011, Pages 153-155

  Papay, Kimberly ^a   Mamikonyan, Eugenia ^a   Siderowf, Andrew D ^a   Duda, John E ^a,b   Lyons, Kelly E ^c   Pahwa, Rajesh ^c   Driver Dunckley, Erika D ^d   Adler, Charles H ^d   Weintraub, Daniel ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Impulse control disorders; Parkinson's disease; QUIP

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; QUESTIONNAIRE FOR IMPULSIVE COMPULSIVE DISORDERS; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; VALIDITY; VOLUNTARY REPORTING;

AGED; FEMALE; HEALTH PERSONNEL; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79951551729     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.11.015     Document Type: Article

References (17)

1. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1-5.
2. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M.A., Voon V., et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
3. Shulman L.M., Taback R.L., Rabinstein A.A., Weiner W.J. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinson Related Disord 2002, 8:193-197.
4. Chaudhuri K.R., Prieto-Jurcynska C., Naidu Y., Mitra T., Frades-Payo B., Tluk S., et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the Nonmotor Symptoms Questionnaire. Mov Disord 2010, 10.1002/mds.22868.
5. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006, 63:969-973.
6. Weintraub D., Stewart S., Shea J.A., Lyons K.E., Pahwa R., Driver-Dunckley E.D., et al. Validation of the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease (QUIP). Mov Disord 2009, 24:1461-1467.
7. Funder D.C., Colvin C.R. Congruence of others' and self-judgments of personality. Handbook of personality 1997, 617-647. Academic Press, San Diego, CA. R. Hogan, J. Johnson, S. Briggs (Eds.).
8. McKinlay A., Grace R.C., Dalrymple-Alford J.C., Anderson T.J., Fink J., Roger D. Neuropsychiatric problems in Parkinson's disease: comparisons between self and caregiver report. Aging Mental Health 2008, 12:647-653.
9. Ready R.E., Clark L.A. Psychiatric patient and informant reports of patient behavior. J Pers 2005, 73:1-21.
10. Grant J.E., Steinberg M.A., Kim S.W., Rounsaville B.J., Potenza M.N. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res 2004, 128:79-88.
11. Lejoyeux M., Tassain V., Solomon J., Adès J. Study of compulsive buying in depressed patients. J Clin Psychiatry 1997, 58:169-173.
12. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 67:1254-1257.
13. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC, Text Revision. fourth ed.
14. Voon V., Fox S.H. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007, 64:1089-1096.
15. Giovannoni G., O'Sullivan J.D., Turner K., Manson A.J., Lees A.J.L. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000, 68:423-428.
16. McGinn T., Wyer P.C., Newman T.B., Keitz S., Leipzig R., Guyatt G., et al. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). Can Med Assoc J 2004, 171:1369-1373.
17. SPSS for Windows [computer program]. Version 17.0 2009, SPSS Inc., Chicago.